These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15473889)

  • 21. Effect of spironolactone on C-reactive protein levels in patients with heart disease.
    Godfrey V; Farquharson CA; Macdonald JE; Yee KM; Struthers AD
    Int J Cardiol; 2007 Apr; 117(2):282-4. PubMed ID: 16899309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
    Pitt B; Fonarow GC; Gheorghiade M; Deedwania PC; Duprez DA
    Am J Cardiol; 2006 May; 97(10A):26F-33F. PubMed ID: 16698332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy.
    Chai W; Hoedemaekers Y; van Schaik RH; van Fessem M; Garrelds IM; Saris JJ; Dooijes D; ten Cate FJ; Kofflard MM; Danser AH
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):225-30. PubMed ID: 17318792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
    Fortuna P; Reis I; Ascenção R; Carneiro AV
    Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone antagonism and atrial fibrillation: time for clinical assessment?
    Nattel S
    Eur Heart J; 2005 Oct; 26(20):2079-80. PubMed ID: 16141259
    [No Abstract]   [Full Text] [Related]  

  • 26. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R; McMurray JJ
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the aldosterone synthase gene C-344T polymorphism with risk factors and survival in a post-myocardial infarction cohort.
    Baird TE; Palmer BR; Frampton CM; Yandle TG; Skelton L; Richards AM; Cameron VA
    J Hum Hypertens; 2007 Mar; 21(3):256-8. PubMed ID: 17215850
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secretion and inactivation of aldosterone in hydropic heart insufficiency].
    Kaufmann W; Steiner B; Dürr F; Meurer KA
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():419-24. PubMed ID: 5380623
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aldosterone and edemas].
    Stajkovac A; Lucić A
    Med Pregl; 1965; 18(9):431-3. PubMed ID: 5886317
    [No Abstract]   [Full Text] [Related]  

  • 32. Aldosterone antagonists.
    GANTT CL
    N Y State J Med; 1961 Mar; 61():756-70. PubMed ID: 13703392
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metabolic investigation with exogenous supply of aldosterone].
    RAUSCH-STROOMANN JG; GLAUBITT D; KAPISCHKE F
    Endokrinologie; 1959 Apr; 37(4):217-30. PubMed ID: 13652924
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of liver homogenates on the transformation of aldosterone into polar metabolites].
    ALBEAUX-FERNET M; ROMANI JD
    C R Seances Soc Biol Fil; 1958; 152(3):428-31. PubMed ID: 13597291
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypoaldosteronism: a new clinical entity].
    Calderon R
    Rev Soc Peru Endocrinol; 1965 May; 2(1):1-2. PubMed ID: 5847377
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aldosterone].
    Labadie P
    Rev Prat; 1973 Oct; 23(45):4027-8 passim. PubMed ID: 4801745
    [No Abstract]   [Full Text] [Related]  

  • 37. [The antialdosterones].
    RAYNAUD R; BROCHIER M
    Alger Medicale; 1961 Apr; 65():239-43. PubMed ID: 13739986
    [No Abstract]   [Full Text] [Related]  

  • 38. Aldosterone: from integrative physiology to cellular biology and back.
    Ertl G
    Eur J Clin Invest; 2004 Oct; 34(10):653-5. PubMed ID: 15473889
    [No Abstract]   [Full Text] [Related]  

  • 39. Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
    Heymes C; Garnier A; Fuchs S; Bendall JK; Nehme J; Ambroisine ML; Robidel E; Swynghedauw B; Milliez P; Delcayre C
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):213-9. PubMed ID: 15134820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of aldosterone blockade in heart failure.
    Pitt B
    Heart Fail Clin; 2005 Apr; 1(1):49-56. PubMed ID: 17386833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.